Le, H.L.; Bouwhuis, N.; Hollak, C.E.M.; Wilhelm, A.J.; Gerards, A.-L.E.; Bijleveld, Y.A.; Swart, E.L.
Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3. Pharmaceutics 2025, 17, 417.
https://doi.org/10.3390/pharmaceutics17040417
AMA Style
Le HL, Bouwhuis N, Hollak CEM, Wilhelm AJ, Gerards A-LE, Bijleveld YA, Swart EL.
Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3. Pharmaceutics. 2025; 17(4):417.
https://doi.org/10.3390/pharmaceutics17040417
Chicago/Turabian Style
Le, Hoang Lan, Natalja Bouwhuis, Carla E. M. Hollak, Abraham J. Wilhelm, Anne-Loes E. Gerards, Yuma A. Bijleveld, and Eleonora L. Swart.
2025. "Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3" Pharmaceutics 17, no. 4: 417.
https://doi.org/10.3390/pharmaceutics17040417
APA Style
Le, H. L., Bouwhuis, N., Hollak, C. E. M., Wilhelm, A. J., Gerards, A.-L. E., Bijleveld, Y. A., & Swart, E. L.
(2025). Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3. Pharmaceutics, 17(4), 417.
https://doi.org/10.3390/pharmaceutics17040417
